Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 39

1.

Perampanel: a novel antiepileptic for the adjunctive treatment of refractory partial onset seizures.

Owen RT.

Drugs Today (Barc). 2013 Jan;49(1):23-31. doi: 10.1358/dot.2013.49.1.1906424. Review.

PMID:
23362493
2.

Perampanel: as adjunctive therapy in patients with partial-onset seizures.

Plosker GL.

CNS Drugs. 2012 Dec;26(12):1085-96. doi: 10.1007/s40263-012-0021-2. Review.

PMID:
23179642
3.

Perampanel, a novel, non-competitive, selective AMPA receptor antagonist as adjunctive therapy for treatment-resistant partial-onset seizures.

Rektor I.

Expert Opin Pharmacother. 2013 Feb;14(2):225-35. doi: 10.1517/14656566.2013.754883. Epub 2012 Dec 23. Review.

PMID:
23259931
4.

Perampanel in the treatment of focal and idiopathic generalized epilepsies and of status epilepticus.

Strzelczyk A, Willems LM, Willig S, Rosenow F, Bauer S.

Expert Rev Clin Pharmacol. 2015;8(6):733-40. doi: 10.1586/17512433.2015.1091303. Epub 2015 Oct 5. Review.

PMID:
26436331
5.

Perampanel: a new agent for adjunctive treatment of partial seizures.

Faulkner MA.

Am J Health Syst Pharm. 2014 Feb 1;71(3):191-8. doi: 10.2146/ajhp130203. Review.

PMID:
24429011
6.

Perampanel for epilepsy with partial-onset seizures: a pharmacokinetic and pharmacodynamic evaluation.

Schulze-Bonhage A.

Expert Opin Drug Metab Toxicol. 2015;11(8):1329-37. doi: 10.1517/17425255.2015.1061504. Epub 2015 Jun 25. Review.

PMID:
26111428
7.

Novel treatment options for epilepsy: focus on perampanel.

Franco V, Crema F, Iudice A, Zaccara G, Grillo E.

Pharmacol Res. 2013 Apr;70(1):35-40. doi: 10.1016/j.phrs.2012.12.006. Epub 2013 Jan 1. Review.

PMID:
23287426
8.

Pharmacotherapy of epilepsy: newly approved and developmental agents.

Stephen LJ, Brodie MJ.

CNS Drugs. 2011 Feb;25(2):89-107. doi: 10.2165/11584860-000000000-00000. Review.

PMID:
21254787
9.

Perampanel for focal epilepsy: insights from early clinical experience.

Trinka E, Steinhoff BJ, Nikanorova M, Brodie MJ.

Acta Neurol Scand. 2016 Mar;133(3):160-72. doi: 10.1111/ane.12529. Epub 2015 Oct 28. Review.

10.

AMPA receptor inhibitors for the treatment of epilepsy: the role of perampanel.

Zaccara G, Giovannelli F, Cincotta M, Iudice A.

Expert Rev Neurother. 2013 Jun;13(6):647-55. doi: 10.1586/ern.13.46. Review.

PMID:
23739002
11.

The discovery and development of perampanel for the treatment of epilepsy.

Hanada T.

Expert Opin Drug Discov. 2014 Apr;9(4):449-58. doi: 10.1517/17460441.2014.891580. Epub 2014 Feb 24. Review.

PMID:
24559052
12.

The AMPA receptor antagonist perampanel is a new hope in the treatment for epilepsy.

El Desoky ES.

Fundam Clin Pharmacol. 2014 Oct;28(5):473-80. doi: 10.1111/fcp.12081. Epub 2014 May 14. Review.

PMID:
24750493
13.

Perampanel: expanding therapeutic options for patients with medically refractory secondary generalized convulsive seizures.

Ko D, Ramsay RE.

Acta Neurol Scand Suppl. 2013;(197):36-43. doi: 10.1111/ane.12103. Review.

14.

Perampanel: A Review in Drug-Resistant Epilepsy.

Frampton JE.

Drugs. 2015 Sep;75(14):1657-68. doi: 10.1007/s40265-015-0465-z. Review.

PMID:
26370209
15.

Safety profile of two novel antiepileptic agents approved for the treatment of refractory partial seizures: ezogabine (retigabine) and perampanel.

Faulkner MA, Burke RA.

Expert Opin Drug Saf. 2013 Nov;12(6):847-55. doi: 10.1517/14740338.2013.823399. Epub 2013 Jul 25. Review.

PMID:
23883095
16.

The adverse event profile of perampanel: meta-analysis of randomized controlled trials.

Zaccara G, Giovannelli F, Cincotta M, Verrotti A, Grillo E.

Eur J Neurol. 2013 Aug;20(8):1204-11. doi: 10.1111/ene.12170. Epub 2013 Apr 23. Review.

PMID:
23607817
17.

Brivaracetam: review of its pharmacology and potential use as adjunctive therapy in patients with partial onset seizures.

Mumoli L, Palleria C, Gasparini S, Citraro R, Labate A, Ferlazzo E, Gambardella A, De Sarro G, Russo E.

Drug Des Devel Ther. 2015 Oct 19;9:5719-25. doi: 10.2147/DDDT.S81474. eCollection 2015. Review. Erratum in: Drug Des Devel Ther. 2015;9:6509.

18.

Adverse effects and safety profile of perampanel: a review of pooled data.

Rugg-Gunn F.

Epilepsia. 2014 Jan;55 Suppl 1:13-5. doi: 10.1111/epi.12504. Review.

19.

Development of perampanel in epilepsy.

Satlin A, Kramer LD, Laurenza A.

Acta Neurol Scand Suppl. 2013;(197):3-8. doi: 10.1111/ane.12098. Review.

20.

Ezogabine: a novel antiepileptic as adjunctive therapy for partial onset seizures.

Owen RT.

Drugs Today (Barc). 2010 Nov;46(11):815-22. doi: 10.1358/dot.2010.46.11.1556435. Review.

PMID:
21225020

Supplemental Content

Support Center